These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23233031)

  • 1. Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus.
    Musso CG; Navarro M; Mombelli C; Giordani C; Groppa R; Martinez B; De Miguel R; Imperiali N
    Int Urol Nephrol; 2013 Oct; 45(5):1471-4. PubMed ID: 23233031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional excretion of K, Na and Cl following furosemide infusion in healthy, young and very old people.
    Musso CG; Reynaldi J; Vilas M; De Miguel R; Imperiali N; Algranati L
    Int Urol Nephrol; 2010 Mar; 42(1):273-7. PubMed ID: 19277890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal potassium handling in chronic kidney disease: Differences between patients with or wihtout hyperkalemia.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(2):152-159. PubMed ID: 31353054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage III chronic kidney disease patients and healthy oldest old.
    Musso CG; Juarez R; Vilas M; Navarro M; Rivera H; Jauregui R
    Int Urol Nephrol; 2012 Oct; 44(5):1559-62. PubMed ID: 22893492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
    Damman K; Ng Kam Chuen MJ; MacFadyen RJ; Lip GY; Gaze D; Collinson PO; Hillege HL; van Oeveren W; Voors AA; van Veldhuisen DJ
    J Am Coll Cardiol; 2011 May; 57(22):2233-41. PubMed ID: 21616283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Between CKD-EPI Creatinine and MDRD Equations to Estimate Glomerular Filtration Rate in Kidney Transplant Patients.
    Mombelli CA; Giordani MC; Imperiali NC; Groppa SR; Ocampo L; Elizalde RI; Schreck CM; Rosa-Diez GJ
    Transplant Proc; 2016 Mar; 48(2):625-30. PubMed ID: 27110017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-MR in kidney transplant recipients: is diuretic stimulation a useful diagnostic tool for improving differentiation between functioning and non-functioning kidneys?
    Palmucci S; Mammino L; Caltabiano DC; Costanzo V; Foti PV; Mauro LA; Farina R; Profitta ME; Sinagra N; Ettorre GC; Veroux M; Basile A
    Clin Imaging; 2019; 53():97-104. PubMed ID: 30317137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular dysfunction in renal transplant patients using sirolimus or tacrolimus.
    Banhara PB; Gonçalves RT; Rocha PT; Delgado AG; Leite M; Gomes CP
    Clin Nephrol; 2015 Jun; 83(6):331-7. PubMed ID: 25943142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of high-dose furosemide on residual renal function in CAPD patients.
    van Olden RW; Guchelaar HJ; Struijk DG; Krediet RT; Arisz L
    Perit Dial Int; 2003; 23(4):339-47. PubMed ID: 12968841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azosemide, a "loop" diuretic, and furosemide.
    Brater DC; Anderson SA; Strowig S
    Clin Pharmacol Ther; 1979 Apr; 25(4):435-9. PubMed ID: 428188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine induced nephrotoxicity in renal transplant recipients: clinical significance of fractional excretion of sodium, potassium and magnesium.
    Naqvi HN; Zafar MN; Hussain A; Naqvi SA; Rizvi AH
    J Pak Med Assoc; 2005 Apr; 55(4):161-5. PubMed ID: 15918629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of loop diuretics in patients with chronic renal insufficiency.
    Voelker JR; Cartwright-Brown D; Anderson S; Leinfelder J; Sica DA; Kokko JP; Brater DC
    Kidney Int; 1987 Oct; 32(4):572-8. PubMed ID: 3430953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study.
    Tominaga N; Kida K; Inomata T; Sato N; Izumi T; Akashi YJ; Shibagaki Y
    Clin Exp Nephrol; 2018 Dec; 22(6):1395-1403. PubMed ID: 29934667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of furosemide on Na and K excretion fractions in patients with allotransplanted kidney.
    Stríbrná J; Matousovic K; Martínek V
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):124-6. PubMed ID: 7014479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Urinary Sodium and Potassium with Renal Uric Acid Excretion in Patients with Chronic Kidney Disease.
    Li F; Guo H; Zou J; Chen W; Lu Y; Zhang X; Fu C; Xiao J; Ye Z
    Kidney Blood Press Res; 2018; 43(4):1310-1321. PubMed ID: 30099444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal potassium excretion: comparison between chronic renal disease patients and old people.
    Musso CG; Miguel Rd; Algranati L; Farias Edos R
    Int Urol Nephrol; 2005; 37(1):167-70. PubMed ID: 16132781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ROMK blocks macula densa tubuloglomerular feedback yet causes renal vasoconstriction in anesthetized rats.
    Araujo M; Welch WJ; Zhou X; Sullivan K; Walsh S; Pasternak A; Wilcox CS
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1120-F1127. PubMed ID: 28228405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.